The Use of Decitabine as Induction Therapy for Acute Myeloid Leukemia With Complex and/or Monosomal Karyotype

NCT03080766 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Complex Karyotype

Interventions

DRUG: Decitabine

Sponsor

The University of Hong Kong

Collaborators

[object Object]